Amazfit Introduces Balance 2 Smartwatch and Helio Strap for Smarter Training, Better Recovery and Peak Performance
Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), a health technology company, today announced the launch and availability of two new performance-focused devices—the Balance 2 smartwatch and the Helio Strap, Amazfit’s first screen-free fitness, recovery, and sleep tracker.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250624910772/en/
Amazfit Introduces Balance 2 Smartwatch and Helio Strap
Better Together: A Smarter Training and Recovery System
While both devices can be purchased and used individually, it's their combined potential as an all-in-one training and recovery system that truly sets them apart. Balance 2 is a premium multisport training partner that gives users access to advanced performance tracking. When paired with the Helio Strap, the system delivers even greater accuracy in heart rate monitoring, fatigue assessment, and recovery analysis. All data syncs effortlessly within the Zepp App, providing a unified ecosystem and experience across all Amazfit devices—no additional apps or subscriptions required.
Balance 2: The Premium Multisport Training Partner
Built for high performers, the new Amazfit Balance 2 supports daily training across multiple sports — perfect for hybrid athletes and anyone balancing gym workouts, strength training, running, cycling, golf, diving, and more. With intelligent tracking, personalized insights, and a design that transitions effortlessly from intense training sessions to workdays and weekend outings, Balance 2 empowers users to excel in every moment. ($299.99 USD; €299.9 euro)
Key Features:
○ Durability and Performance: Scratch-resistant 1.5-inch Sapphire glass screen with an AMOLED display and up to 2000 nits of brightness for excellent visibility in any lighting and sustained performance, plus 10 ATM water resistance and 21-day battery life.
○ HYROX-Optimized Training: As the Official Timekeeper of HYROX, Amazfit is the first—and only—brand with three dedicated HYROX modes. Specifically designed to support the demands of structured HYROX workouts, it lets users plan intervals, heart rate zones, transitions, and recovery—then track and analyze it all in the Zepp App for smarter performance and faster recovery.
○ Enhanced Monitoring: More accurate monitoring of key biometrics, including exercise heart rate, HRV, blood oxygen level, sleep patterns and more.
○ Free Downloadable Maps ideal for both city running and weekend adventures.
○ Advanced Golf Features: Amazfit’s first smartwatch with a full in-round golf experience—40K+ course maps, pin relocation, hazards, scoring, and swing feedback like swing plane and tempo. With golf now built in, Balance 2 is an all-in-one watch for work, workouts, and the course—no separate golf watch needed.
○ Dedicated Diving Support: With 100-meter water resistance, Balance 2 supports both freediving and scuba diving up to 45 meters, enabling accurate tracking and enhanced safety for underwater performance.
○ 170+ Sport Modes, including running, swimming, strength training, HIIT, pickleball, and more.
○ All-New BioCharge™ Score (Coming soon): A personalized body energy management feature that continuously analyzes energy levels in real time by integrating data from sleep, naps, exertion, and stress helping users balance activity and recovery for better performance.
Helio Strap: Screen-Free, Distraction-Free, Subscription-Free Performance Tracking
Helio Strap is Amazfit’s first screen-free tracker designed to deliver fitness, sleep, and recovery data with exceptional comfort and no distractions. Ideal for athletes of all levels, Helio Strap captures advanced metrics and offers the freedom to train smarter and recover better—all with no subscription required. It pairs seamlessly with Amazfit smartwatches, including Balance 2, Helio Ring, and the Zepp App. ($99.99 USD; €99.9 euro)
Key Features:
○ 10-Day Battery Life: Train, recover, and repeat without missing a beat. The Helio Strap can last up to 10 days from a single charge.
○ Continuous Heart Rate Monitoring: Delivers high-precision heart rate tracking 24/7, enabling users to better understand training load, recovery status, and overall cardiovascular health—all without needing to check a screen or interrupt their routine.
○ 27 Workout Modes accessible through the Zepp App, each tailored to capture key performance metrics and optimize training across a wide range of activities—including running, walking, cycling, and indoor gym workouts like strength training, HIIT, yoga, and more.
○ Strength Training & HYROX Modes: Advanced strength training features with detailed tracking for reps, sets, and rest periods, plus exclusive HYROX Race Mode with race-specific and benchmark training tools.
○ All-New BioCharge™ Score: Available now on Helio Strap, BioCharge is a personalized body energy management feature that continuously analyzes energy levels in real time by integrating data from sleep, naps, exertion, and stress helping users balance activity and recovery for better performance.
“Through a single app, these two devices work seamlessly together—whether it’s during training or recovery monitoring. Each one complements and fills in the gaps of the other, enabling more accurate, cross-referenced data. This means more precise insights for the user, all within one simple, unified system,” said Wayne Huang, CEO of Zepp Health. “With no subscriptions, advanced tracking, and effortless syncing, this duo redefines what wearables can do—whether you’re a competitive athlete or simply striving to be your best.”
Availability and Pricing
The Amazfit Balance 2 smartwatch will be available for $299.99 USD; €299.9 euro, while the Helio Strap will retail for $99.99 USD; €99.9 euro —both launching globally on June 24 via Amazfit.com, Amazon, and select retailers. For users seeking the ultimate performance and recovery solution, the Balance 2 + Helio Strap bundle will be offered at a special price of $379.99 USD.
Please visit https://www.amazfit.com/en/ and follow us on Facebook, Instagram, X (formerly Twitter) and YouTube.
About Amazfit
Amazfit, a leading global smart wearable brand focused on health and fitness, is part of Zepp Health (NYSE: ZEPP), a health technology company with its principal office based in Gorinchem, the Netherlands. Zepp Health operates as a distributed organization, with team members and offices across the Americas, Europe, Asia, and other global markets.
Offering a wide selection of smartwatches and bands, Amazfit's brand tagline, “Discover Amazing,” encourages individuals to break barriers, exceed expectations, and find joy in every moment. Amazfit is powered by Zepp Health’s proprietary health management platform, which delivers cloud-based, 24/7 actionable insights and guidance to help users achieve their wellness goals.
Known for outstanding craftsmanship, Amazfit smartwatches have won numerous design awards, including the iF Design Award and the Red Dot Design Award. Launched in 2015, Amazfit is embraced by millions of users, with products available in over 90 countries across the Americas, EMEA, and APAC regions. For more information, visit www.amazfit.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250624910772/en/
Contacts
Media Contact
Mary Thompson Woodbury
Head of PR, North America
mary.woodbury@zepp.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
GENESIS Pharma announces a new partnership with Otsuka Pharmaceutical Europe Ltd. for the commercialization of donidalorsen for hereditary angioedema in Central and Eastern Europe15.12.2025 10:00:00 CET | Press Release
ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GENESIS Pharma, a regional biopharma company focused on the commercialization of innovative medicines in Central and Eastern Europe, announces an exclusive agreementwithOtsuka Pharmaceutical Europe Ltd. (OPEL), the European operation of global healthcare company Otsuka Pharmaceutical Co., Ltd., for donidalorsen. Under the terms of the agreement, GENESIS Pharma will exclusively distribute and commercializedonidalorsen in fourteen markets: Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia and Slovenia. In November 2025, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for donidalorsen in the routine prevention of recurrent attacks of hereditary angioedema (HAE) in adults and adolescents aged 12 years and older. The CHMP opinion is c
BitGo yn Sicrhau Cymeradwyaeth OCC i Drosi i Fanc Ymddiriedolaeth Genedlaethol Siartredig Ffederal13.12.2025 02:13:00 CET | Pressmeddelande
Cyhoeddodd BitGo Holdings, Inc. (“BitGo”), y cwmni seilwaith asedau digidol, heddiw fod Swyddfa Rheolwr yr Arian Cyfred (“OCC”) wedi cymeradwyo ei gais i drosi BitGo Trust Company, Inc., cwmni ymddiriedolaeth siartredig De Dakota, i fanc cenedlaethol o'r enw BitGo Bank & Trust, National Association (N.A.). Gyda chymeradwyaeth OCC heddiw o'i drosi, mae is-gwmni Cwmni Ymddiriedolaeth BitGo bellach yn gweithredu fel BitGo Bank & Trust, National Association (N.A.). Bydd BitGo Bank & Trust, N.A. yn gweithredu o dan un gyfundrefn oruchwylio ffederal unffurf, gan ei alluogi i ddarparu'r eglurder, y llywodraethiant, a'r sicrwydd rheoleiddiol y mae sefydliadau'n eu disgwyl gan ymddiriedolwr a reoleiddir yn ffederal. Mae'r gymeradwyaeth hon yn atgyfnerthu safle BitGo fel sylfaen sefydliadol ar gyfer y system ariannol fodern, gan gyfuno goruchwyliaeth ar lefel banc â'r diogelwch, y cydymffurfiaeth, a'r graddadwyedd sy'n diffinio seilwaith BitGo. O dan siarter y banc cenedlaethol, ac yn amodol ar
FIA, Formula 1 Group and All 11 Race Teams Officially Sign the Ninth Concorde Agreement, Securing Strength and Stability for the Sport in Pivotal Five-Year Agreement12.12.2025 17:10:00 CET | Press Release
The Fédération Internationale de l'Automobile (FIA), the global governing body for motor sport and the federation for mobility organisations worldwide, and Formula 1 Group, the Commercial Rights Holder, have today announced the signing of the Concorde Governance Agreement, a crucial contract defining the regulatory framework and governance terms of the FIA Formula One World Championship until 2030. This follows the announcement in March that the 2026 Commercial Concorde Agreement had been signed by all the teams and Formula 1 Group. Together, these agreements constitute the ninth Concorde Agreement, representing a major step forward in the professionalisation and global development of the sport. First introduced in 1981, the Concorde Agreements are designed to promote sporting fairness, technological innovation and operational excellence, and align all key stakeholders around a shared vision for structured governance and continued growth of the sport. Each iteration of the Concorde Agr
Anabranch Capital Management, LP supports relisting of SmartCraft ASA to Nasdaq Stockholm12.12.2025 16:26:00 CET | Press Release
Reference is made to the stock exchange announcement by SmartCraft ASA ("SmartCraft" or the "Company") on 1 December 2025 regarding the contemplated relisting of SmartCraft from Euronext Oslo Børs to Nasdaq Stockholm (the "Relisting") and the announcement of a cross-border merger to effect the Relisting. Funds managed by Anabranch Capital Management, LP (“Anabranch”) intend to vote in favour of the merger plan resolved by the boards of SmartCraft and its Swedish wholly owned subsidiary, SmartCraft Group AB (publ), to effect the Relisting at the Company's extraordinary general meeting planned for January 2025 (the "EGM"). Anabranch intends to vote with all Anabranch shares held at the Record Date for the EGM in favour of the relisting effected by the merger plan. Funds managed by Anabranch currently hold approximately 15.9 million shares in SmartCraft. Disclaimer: The views expressed are those of the authors and Anabranch Capital Management, LP as of the date referenced and are subject
Mohammed Ben Sulayem Re-Elected as President of the FIA12.12.2025 15:49:00 CET | Press Release
The Fédération Internationale de l’Automobile (FIA), the global governing body for motor sport and the federation for mobility organisations worldwide, today confirms that Mohammed Ben Sulayem has been re-elected as President of the FIA, following the election of his Presidential List by the General Assembly in Tashkent, Republic of Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251212213181/en/ President Mohammed Ben Sulayem now begins his second four-year term, having overseen a period of significant renewal and stabilisation for the organisation since his initial election in 2021. Over the past four years, the FIA has undergone a wide-ranging transformation, improving governance, operations and restoring the financial health of the federation. These changes have strengthened the FIA’s position as the world’s governing body for motorsport and the leading authority on safe, sustainable, and affordable mobility.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom